Document is current
Any future updates will be listed below
-
Authors
Bouveret, Zélie
Pruvost, Ludivine
Trédan, Olivier
Le Romancer, Muriel
Poulard, Coralie
-
Funding
Funding for this research was provided by:
Fondation ARC pour la Recherche sur le Cancer
Ligue Contre le Cancer
Agence Nationale de la Recherche (ANR-22-CE13-0001-01)
- License Information
-
More Information
Article History
Received: 9 March 2026
Accepted: 14 June 2026
First Online: 20 June 2026
Declarations
:
: O.T. received honoraria and grants from: Roche, Pfizer, Novartis, Lilly, MSD, Astra-Zeneca, Seagen, Daiichi-Sankyo, Gilead, BMS, Sandoz, Viatris, Menarini-Stemline, Veracyte, Exact Sciences.
